Clinical significance of immune cell and biomarker changes in liver cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

202

Figures (1-2)

128

Tables (1-4)

118

Sum=463

Publishing Process of This Article

Item

Count

Browse

Download

Sum=55

Jun 27, 2025 (publication date) through Jun 24, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Surg. Jun 27, 2025; 17(6): 104923
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104923

Table 3 Comparison of peripheral serum tumor marker levels in the two groups (mean ± SD)

AFP: Alpha fetoprotein; GGT: Gamma-glutamyl transpeptidase; PLC: Primary liver cancer.

Citation: Zhou ST, Zhang B, Ma K, Guo J. Clinical significance of immune cell and biomarker changes in liver cancer. World J Gastrointest Surg 2025; 17(6): 104923
URL: https://www.wjgnet.com/1948-9366/full/v17/i6/104923.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.104923